Difference between revisions of "LncRNAWiki:Featured"
(64 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
− | |||
− | |||
− | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
− | !width="50"| | + | !width="50"|LncBook ID |
− | !width="50"| | + | !width="50"|Symbol |
− | !width="50"| | + | !width="50"|Synonyms |
− | !width="50"| | + | !width="50"|Functional Mechanism |
+ | !width="50"|Biological Process | ||
!width="50"|Disease | !width="50"|Disease | ||
+ | !width="50"|Mesh Ontology | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] |
− | |[[ | + | |[[HPVC1]] |
− | | | + | |PE5L,HPV18E5L |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605] |
− | |[[ | + | |[[NONHSAT104559]] |
− | | | + | |lnc-C9orf53-2:1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632] |
− | |[[ | + | |[[N4BP2L2-IT2]] |
− | | | + | |CG030 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094] |
− | |[[ | + | |[[LINC01150]] |
− | | | + | |2G7,TCONS_00019134 |
− | | | + | |NA |
− | |tumor | + | |pathogenic process |
+ | |Wilms' tumor | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115] |
− | |[[ | + | |[[LINC01587]] |
− | | | + | |C4orf6,aC1 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |neuroblastoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105] |
− | |[[ | + | |[[NONHSAT115106]] |
− | | | + | |NONHSAT115106 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234] |
− | |[[ | + | |[[RNF217-AS1]] |
− | | | + | |STL |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481] |
− | |[[ | + | |[[INE2]] |
− | | | + | |NCRNA00011 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485] |
− | |[[ | + | |[[INE1]] |
− | | | + | |NCRNA00010 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511] |
− | |[[ | + | |[[LINC01565]] |
− | | | + | |C3orf27,GR6 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |leukemia | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068] |
− | |[[ | + | |[[LINC00869]] |
− | | | + | |KIAA0493 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430] |
− | |[[ | + | |[[ERC2-IT1]] |
− | | | + | |C1orf1,C3orf51,Po42 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394] |
− | |[[ | + | |[[Lnc-PDIA4-1:1]] |
− | | | + | |lnc-PDIA4-1:1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195] |
− | |[[ | + | |[[NOP14-AS1]] |
− | | | + | |C4orf10,RES4-24 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309] |
− | |[[ | + | |[[NONHSAT022116]] |
− | | | + | |NONHSAT022116,AF080092,TSU |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243] |
− | |[[ | + | |[[SMAD5-AS1]] |
− | | | + | |SMAD5O,DAMS |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |malignant hematopoietic | ||
+ | |Cell Physiological Phenomena | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025] |
− | |[[ | + | |[[LINC00244]] |
− | | | + | |C7orf4,NCRNA00244 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |preaxial polydactyly | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017] |
− | |[[ | + | |[[KIF25-AS1]] |
− | | | + | |C6orf54,NCRNA00300,HGC6.1.1 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332] |
− | |[[ | + | |[[LINC01558]] |
− | | | + | |C6orf123,LINC01557,HGC6.2,dJ431P23.4 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |ovarian cancer | ||
+ | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438] |
− | |[[ | + | |[[AFDN-AS1]] |
− | | | + | |C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232] |
− | |[[ | + | |[[RFPL3S]] |
− | | | + | |RFPL3-AS1,RFPL3-A, NCRNA00005 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |opitz syndrome | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393] |
− | |[[ | + | |[[RFPL1S]] |
− | | | + | |RFPL1-AS1,RFPL1-A, NCRNA00006 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500] |
− | |[[ | + | |[[HCG4B]] |
− | | | + | |HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 |
− | + | |NA | |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894] |
− | |[[ | + | |[[LINC00294]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345] |
− | |[[ | + | |[[LINC00893]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |hunter syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133] |
− | |[[ | + | |[[PCBP3-OT1]] |
− | | | + | |PCBP3-OT1,FLJ44028 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488] |
− | |[[ | + | |[[ENST00000418282.1]] |
− | | | + | |NCRNA00187 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |blepharophimosis syndrome | ||
+ | |Eye Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712] |
− | |[[ | + | |[[COPG2IT1]] |
− | | | + | |CIT1,NCRNA00170,COPG2AS |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040] |
− | |[[ | + | |[[LINC00652]] |
− | | | + | |HSPC072 |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282] |
− | |[[ | + | |[[WASIR2]] |
− | | | + | |NCRNA00286A |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856] |
− | |[[ | + | |[[LINC00470]] |
− | | | + | |C18orf2 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |age-related macular degeneration | ||
+ | |Eye Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507] |
− | |[[ | + | |[[LINC00588]] |
− | | | + | |C8orf71,DKFZP434F122 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604] |
− | |[[ | + | |[[TTC28-AS1]] |
− | | | + | |TTC28AS,TTC28-AS,KIAA1648 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577] |
− | |[[ | + | |[[CDRT7]] |
− | | | + | |NCRNA00025,LINC00025 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912] |
− | |[[ | + | |[[CDRT8]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048] |
− | |[[ | + | |[[CECR3]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915] |
− | + | |[[CECR9]] | |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998] |
− | |[[ | + | |[[HDHD5-AS1]] |
− | | | + | |CECR4,CECR5-AS1,NCRNA00017 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914] |
− | |[[ | + | |[[CECR5-AS1]] |
− | | | + | |NCRNA00017 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |cat eye syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919] |
− | |[[ | + | |[[CLRN1-AS1]] |
− | | | + | |CLRN1O,UCRP |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |usher syndrome type 3 | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271] |
− | |[[ | + | |[[TMEM9B-AS1]] |
− | | | + | |C11orf18 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324] |
− | |[[ | + | |[[LINC01547]] |
− | | | + | |C21orf69,C21orf67 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Down syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409] |
− | |[[ | + | |[[LINC00029]] |
− | | | + | |C20orf51,NCRNA00029,bA305P22.4 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336] |
− | |[[ | + | |[[LINC00529]] |
− | | | + | |C8orf8 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |keratolytic winter erythema | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978] |
− | |[[ | + | |[[FLVCR1-AS1]] |
− | | | + | |FLVCR1-DT,LQK1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050] |
− | |[[ | + | |[[SMCR2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401] |
− | |[[ | + | |[[SMCR5]] |
− | | | + | |NCRNA00034 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246] |
− | |[[ | + | |[[SMCR6]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Smith-Magenis syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626] |
− | |[[ | + | |[[LINC00205]] |
− | | | + | |C21orf86,NCRNA00205, |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512] |
− | |[[ | + | |[[C21orf91-OT1]] |
− | | | + | |NCRNA00285,D21S2089E |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596] |
− | |[[ | + | |[[LINC00307]] |
− | | | + | |NCRNA00307,D21S2091E |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502] |
− | |[[ | + | |[[TSPEAR-AS2]] |
− | | | + | |C21orf90 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807] |
− | |[[ | + | |[[MCM3AP-AS1]] |
− | | | + | |C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888] |
− | |[[ | + | |[[B3GALT5-AS1]] |
− | | | + | |C21orf88 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898] |
− | |[[ | + | |[[BRWD1-AS2]] |
− | | | + | |C21orf87,NCRNA00257,BRWD1-IT2 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031] |
− | |[[ | + | |[[LINC00315]] |
− | | | + | |C21orf93,NCRNA00315 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033] |
− | |[[ | + | |[[LINC00334]] |
− | | | + | |C21orf89,NCRNA00334 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322] |
− | |[[ | + | |[[LINC00314]] |
− | | | + | |C21orf94,NCRNA00314 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821] |
− | |[[ | + | |[[LINC00308]] |
− | | | + | |C21orf74,NCRNA00308,PRED16 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023] |
− | |[[ | + | |[[LINC00189]] |
− | | | + | |C21orf109,NCRNA00189 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375] |
− | |[[ | + | |[[NCRUPAR]] |
− | | | + | |ncR-uPAR,ncRuPAR,NCRNA00193 |
− | | | + | |transcriptional regulation |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467] |
− | |[[ | + | |[[DSCR10]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480] |
− | |[[ | + | |[[DSCR9]] |
− | | | + | |NCRNA00038 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051] |
− | |[[ | + | |[[MDS2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |myelodysplastic syndrome | ||
+ | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810] |
− | |[[ | + | |[[ST7-AS2]] |
− | | | + | |ST7OT2,ST7AS2 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |autism | ||
+ | |Mental Disorders | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813] |
− | |[[ | + | |[[ST7-OT3]] |
− | | | + | |ST7OT3,NCRNA00026 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |autism | ||
+ | |Mental Disorders | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258] |
− | |[[ | + | |[[ST7-OT4]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |autism | ||
+ | |Mental Disorders | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257] |
− | |[[ | + | |[[NONHSAT122926]] |
− | | | + | |NONHSAT122926 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372] |
− | |[[ | + | |[[MIR600HG]] |
− | | | + | |C9orf45,NCRNA00287,GL012,FLJ22161 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239] |
− | |[[ | + | |[[ATP1A1-AS1]] |
− | | | + | |C1orf203,ATP1A1OS,MGC16179 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563] |
− | |[[ | + | |[[SPATA3-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859] |
− | |[[ | + | |[[LINC00852]] |
− | | | + | |C3orf42,GHRLOS2,NAG73,GHRL-AS2 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395] |
− | |[[ | + | |[[LINC01096]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367] |
− | |[[ | + | |[[LINC02260]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259] |
− | |[[ | + | |[[LINC01091]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480] |
− | |[[ | + | |[[SAP30L-AS1]] |
− | | | + | |FLJ38109,GALNT10-AS1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558] |
− | |[[ | + | |[[PRR7-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356] |
− | |[[ | + | |[[LINC01622]] |
− | | | + | |TCONS_00011202 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415] |
− | |[[ | + | |[[LINC01312]] |
− | | | + | |MGC34034 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652] |
− | |[[ | + | |[[EXTL3-AS1]] |
− | | | + | |C8orf50 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253] |
− | |[[ | + | |[[C8orf34-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876] |
− | |[[ | + | |[[PSMD5-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228] |
− | |[[ | + | |[[LINC01553]] |
− | | | + | |C10orf40,AC023904.2 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689] |
− | |[[ | + | |[[LINC00301]] |
− | | | + | |C11orf64,NCRNA00301,MGC39681 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235] |
− | |[[ | + | |[[DLGAP1-AS3]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200] |
− | |[[ | + | |[[CIRBP-AS1]] |
− | | | + | |C19orf23,MGC39338 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335] |
− | |[[ | + | |[[LINC01785]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582] |
− | |[[ | + | |[[LINC01869]] |
− | | | + | |MGC45922 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743] |
− | |[[ | + | |[[LINC01711]] |
− | | | + | |MGC4294 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468] |
− | |[[ | + | |[[FAM41AY1]] |
− | | | + | |FAM41AY |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899] |
− | |[[ | + | |[[C5orf66-AS2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922] |
− | |[[ | + | |[[CSTF3-AS1]] |
− | | | + | |CSTF3-DT |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923] |
− | |[[ | + | |[[CYP1B1-AS1]] |
− | | | + | |C2orf58,MGC34824 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957] |
− | |[[ | + | |[[ENTPD3-AS1]] |
− | | | + | |FLJ36665 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970] |
− | |[[ | + | |[[FAM27E3]] |
− | | | + | |MGC42630 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972] |
− | |[[ | + | |[[FAM41C]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977] |
− | |[[ | + | |[[FLG-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983] |
− | |[[ | + | |[[GABPB1-IT1]] |
− | | | + | |FLJ10038 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010] |
− | |[[ | + | |[[ILF3-AS1]] |
− | | | + | |ILF3-DT |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034] |
− | |[[ | + | |[[LINC00347]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039] |
− | |[[ | + | |[[LINC00466]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040] |
− | |[[ | + | |[[LINC00471]] |
− | | | + | |C2orf52,MGC43122 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044] |
− | |[[ | + | |[[LINC00526]] |
− | | | + | |C18orf18,MGC17515,HsT959 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048] |
− | |[[ | + | |[[LINC00593]] |
− | | | + | |C15orf50,MGC42951 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050] |
− | |[[ | + | |[[LINC00608]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054] |
− | |[[ | + | |[[LINC00638]] |
− | | | + | |MGC23270 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056] |
− | |[[ | + | |[[LINC00661]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057] |
− | |[[ | + | |[[LINC00662]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062] |
− | |[[ | + | |[[LINC00692]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064] |
− | |[[ | + | |[[LINC00705]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067] |
− | |[[ | + | |[[LINC00868]] |
− | | | + | |C17orf52 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693] |
− | |[[ | + | |[[LINC00996]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101] |
− | |[[ | + | |[[LINC01252]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131] |
− | |[[ | + | |[[LINC02135]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193] |
− | |[[ | + | |[[NIFK-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244] |
− | |[[ | + | |[[SMG7-AS1]] |
− | | | + | |DKFZP564C196 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326] |
− | |[[ | + | |[[SNAI3-AS1]] |
− | | | + | |MGC23284 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205] |
− | |[[ | + | |[[SNHG10]] |
− | | | + | |C14orf62,FLJ40557,NCRNA00063,LINC00063 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290] |
− | |[[ | + | |[[ZNF205-AS1]] |
− | | | + | |MGC3771 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294] |
− | |[[ | + | |[[LINC00260]] |
− | | | + | |C1orf217,NCRNA00260,MGC5457 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295] |
− | |[[ | + | |[[LINC00337]] |
− | | | + | |C1orf211,NCRNA00337,MGC40168 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298] |
− | |[[ | + | |[[WAC-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299] |
− | |[[ | + | |[[LINC00839]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303] |
− | |[[ | + | |[[LINC00612]] |
− | | | + | |C12orf33,MGC40170,FLJ41814 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312] |
− | |[[ | + | |[[LINC00663]] |
− | | | + | |MGC39821 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320] |
− | |[[ | + | |[[LINC00494]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330] |
− | |[[ | + | |[[LINC01019]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333] |
− | |[[ | + | |[[LINC00265]] |
− | | | + | |NCRNA00265,NCRNA00265-1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334] |
− | |[[ | + | |[[LINC00689]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337] |
− | |[[ | + | |[[LINC01591]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340] |
− | |[[ | + | |[[LINC01501]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346] |
− | |[[ | + | |[[LINC01560]] |
− | | | + | |CXorf24 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352] |
− | |[[ | + | |[[LINC01959]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353] |
− | |[[ | + | |[[LINC02175]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354] |
− | |[[ | + | |[[LINC02209]] |
− | | | + | |FAM183CP |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359] |
− | |[[ | + | |[[LINGO1-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362] |
− | |[[ | + | |[[MAFG-AS1]] |
− | | | + | |MAFG-DT |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373] |
− | |[[ | + | |[[MORF4L2-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381] |
− | |[[ | + | |[[NPHP3-AS1]] |
− | | | + | |NCRNA00119 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385] |
− | |[[ | + | |[[PAXIP1-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413] |
− | + | |[[TOLLIP-AS1]] | |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416] |
− | |[[ | + | |[[LINC00311]] |
− | | | + | |TMEM148,NCRNA00311,MGC22001 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422] |
− | |[[ | + | |[[ZNF252P-AS1]] |
− | | | + | |C8orf77 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423] |
− | |[[ | + | |[[ZNF436-AS1]] |
− | | | + | |C1orf213,FLJ90508 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429] |
− | |[[ | + | |[[BFSP2-AS1]] |
− | | | + | |MGC2848 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432] |
− | + | |[[CTBP1-DT]] | |
− | | | + | |C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436] |
− | |[[ | + | |[[EXOC3-AS1]] |
− | | | + | |C5orf55 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441] |
− | |[[ | + | |[[HCG27]] |
− | | | + | |bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450] |
− | |[[ | + | |[[BAALC-AS2]] |
− | | | + | |C8orf56,BAALCOS,MGC39526 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453] |
− | |[[ | + | |[[FAM87A]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459] | ||
+ | |[[JMJD1C-AS1]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465] | ||
+ | |[[ATP2B1-AS1]] | ||
+ | |LINC00936 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466] | |
− | |[ | + | |[[CEP83-AS1]] |
− | | | + | |CEP83-DT |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470] |
− | |[[ | + | |[[HEXA-AS1]] |
− | | | + | |C15orf34,FLJ13315 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487] |
− | + | |[[BIN3-IT1]] | |
− | | | + | |FLJ14107 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490] |
− | |[[ | + | |[[CSNK1G2-AS1]] |
− | | | + | |C19orf34,MGC39696 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508] |
− | |[[ | + | |[[LINC00634]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510] |
− | |[[ | + | |[[LINC00685]] |
− | | | + | |CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515] |
|[[SHANK2-AS3]] | |[[SHANK2-AS3]] | ||
− | | | + | |C11orf76 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073] |
− | |[[ | + | |[[NCBP2-AS2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502] |
− | |[[ | + | |[[NONHSAT095745]] |
− | | | + | |NCRNA00099,UM9-5 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856] |
− | |[[ | + | |[[GTSCR1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Gilles de la Tourette syndrome | ||
+ | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325] |
− | |[[ | + | |[[LINC00272]] |
− | | | + | |C1orf120,NCRNA00272,RP1-223H12.3 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512] |
− | |[[ | + | |[[TTTY9B]] |
− | | | + | |NCRNA00132 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155] |
− | |[[ | + | |[[Prion-associated RNAs]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |prion disease | ||
+ | |Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444] |
− | |[[ | + | |[[BLACE]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |acute B lymphoblastic leukemias | ||
+ | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411] |
− | |[[ | + | |[[H1FX-AS1]] |
− | | | + | |C3orf47,FLJ34151 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668] |
− | |[[ | + | |[[LINC00477]] |
− | | | + | |C12orf67,FLJ32894,FAM191B |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096] |
− | |[[ | + | |[[LINC00528]] |
− | | | + | |C22orf37,FLJ40542 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824] |
− | |[[ | + | |[[ASMTL-AS1]] |
− | | | + | |CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887] |
− | |[[ | + | |[[ANP32A-IT1]] |
− | | | + | |C15orf28,NCRNA00321,FLJ11722,HsT18971 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396] |
− | |[[ | + | |[[RUSC1-AS1]] |
− | | | + | |C1orf104,FLJ35976 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628] |
− | |[[ | + | |[[LINC01194]] |
− | | | + | |CT49,TAG |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |melanoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468] |
− | |[[ | + | |[[NONHSAT040032]] |
− | | | + | |C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060] |
− | |[[ | + | |[[NPSR1-AS1]] |
− | | | + | |AAA1,IMAGE:4827585 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370] |
− | |[[ | + | |[[LINC00575]] |
− | | | + | |C4orf11 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345] |
− | |[[ | + | |[[LINC01602]] |
− | | | + | |T1560 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433] | ||
+ | |[[FAM13A-AS1]] | ||
+ | |FAM13A1OS,FAM13AOS,NCRNA00039 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186] | ||
+ | |[[MIRLET7DHG]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254] |
− | |[[ | + | |[[MIR181A2HG]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283] |
− | |[[ | + | |[[WDFY3-AS2]] |
− | | | + | |C4orf12,NCRNA00247,FBI4 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555] |
− | |[[ | + | |[[PAPPA-AS1]] |
− | | | + | |PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307] |
− | |[[ | + | |[[LINC00293]] |
− | | | + | |BEYLA |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983] |
− | |[[ | + | |[[SIX3-AS1]] |
− | | | + | |SIX3OS |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503] |
− | |[[ | + | |[[Lnc-C14orf101-5:1]] |
− | | | + | |OTX2OS1 |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422] |
− | |[[ | + | |[[LINC01192]] |
− | | | + | |CT64 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123] |
− | |[[ | + | |[[LINC01193]] |
− | | | + | |CT60,LOC348120 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664] |
|[[C1QTNF9B-AS1]] | |[[C1QTNF9B-AS1]] | ||
|PCOTH | |PCOTH | ||
− | | | + | |NA |
+ | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623] |
− | |[[ | + | |[[ATP6V1G2-DDX39B]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |dilated cardiomyopathy | ||
+ | |Cardiovascular Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498] |
− | |[[ | + | |[[FAM226B]] |
− | | | + | |CXorf50B,NCRNA00246B,LINC00246B |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321] |
− | |[[ | + | |[[LINC00163]] |
− | | | + | |C21orf134,NCRNA00163,NLC1-A,NLC1A |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |narcolepsy | ||
+ | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505] |
− | |[[ | + | |[[LINC00165]] |
− | | | + | |C21orf135,NCRNA00165,NLC1-B |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297] |
− | |[[ | + | |[[NONHSAT035776]] |
− | | | + | |ENSG00000251002 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212] |
− | |[[ | + | |[[LINC00322]] |
− | | | + | |C21orf136,NCRNA00322,FLJ16545 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741] |
− | |[[ | + | |[[NONHSAT102417]] |
− | | | + | |DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527] |
− | |[[ | + | |[[NONHSAT128494]] |
− | | | + | |ncRNA 21A,NONHSAT128494 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409] |
− | |[[ | + | |[[TLX1NB]] |
− | | | + | |TD1,TDI,APT-B7 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |leukemogenesis | ||
+ | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662] |
− | |[[ | + | |[[C15orf2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097] |
− | |[[ | + | |[[NPAP1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Angelman syndrome | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406] |
− | |[[ | + | |[[NONHSAT040875]] |
− | | | + | |NCRNA00199 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227] |
− | |[[ | + | |[[NONHSAT040920]] |
− | | | + | |NCRNA00198 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Prader-Willi syndrome | ||
+ | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816] | ||
+ | |[[MIMT1]] | ||
+ | |MIM1,NCRNA00067,LINC00067 | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180] |
− | |[[ | + | |[[MIR34AHG]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357] |
− | |[[ | + | |[[LINC02570]] |
− | | | + | |XXbac-BPG27H4.8 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |MHC-associated diseases | ||
+ | |Immune System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177] |
− | |[[ | + | |[[RNY1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | ||
+ | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378] |
− | |[[ | + | |[[NKX2-2-AS1]] |
− | | | + | |NKX2-2AS |
− | | | + | |transcriptional regulation |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151] |
− | |[[ | + | |[[NONHSAT023851]] |
− | | | + | |FJ515872.1,NONHSAT023851 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607] |
− | |[[ | + | |[[Anti-NOS2A]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |meningioma;glioblastoma | ||
+ | |Neoplasms;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687] |
|[[CDKN1A-AS1]] | |[[CDKN1A-AS1]] | ||
|p21NAT | |p21NAT | ||
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668] |
− | |[[ | + | |[[RPS6KA2-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |breast cancer | ||
+ | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384] |
− | |[[ | + | |[[PAPPA-AS2]] |
− | | | + | |AGU1 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802] |
− | |[[ | + | |[[ZIM2-AS1]] |
− | | | + | |ZIM2as |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824] |
− | |[[ | + | |[[Lnc-DLX5-3:1]] |
− | | | + | |Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481] |
− | |[[ | + | |[[ADORA2A-AS1]] |
− | | | + | |C22orf45,FLJ34651 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146] |
− | |[[ | + | |[[POU5F1P4]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033] |
− | |[[ | + | |[[LSINCT1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034] |
− | |[[ | + | |[[LSINCT10]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035] |
− | |[[ | + | |[[LSINCT11]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036] |
− | |[[ | + | |[[LSINCT12]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037] |
− | |[[ | + | |[[LSINCT2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038] |
− | |[[ | + | |[[LSINCT3]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039] |
− | |[[ | + | |[[LSINCT4]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041] |
− | |[[ | + | |[[LSINCT6]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042] |
− | |[[ | + | |[[LSINCT7]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043] |
− | |[[ | + | |[[LSINCT8]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044] |
− | |[[ | + | |[[LSINCT9]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer;breast cancer | ||
+ | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676] |
− | |[[ | + | |[[NONHSAT016928]] |
− | | | + | |FLJ31066,NONHSAT016928,lnc-FANK1-3:1 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032] |
− | |[[ | + | |[[LRRC3DN]] |
− | | | + | |C21orf30,DKFZP434C128 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984] |
− | |[[ | + | |[[SNHG11]] |
− | | | + | |C20orf198,LINC00101,NCRNA00101 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |obesity | ||
+ | |Nutritional and Metabolic Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880] |
− | |[[ | + | |[[NONHSAT113225]] |
− | | | + | |NONHSAT113225,ENSG00000220635 |
− | | | + | |ceRNA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] |
− | |[[ | + | |[[ENST00000444042.2]] |
− | | | + | |ncRNA-a3 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470] |
− | |[[ | + | |[[ENST00000417473.2]] |
− | | | + | |ncRNA-a5 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066] |
− | |[[ | + | |[[ENST00000429328.2]] |
− | | | + | |PDZK1IP1-AS1,ncRNA-a4 |
− | | | + | |transcriptional regulation |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936] |
− | |[[ | + | |[[NONHSAT059436]] |
− | | | + | |ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705] |
− | |[[ | + | |[[CHL1-AS2]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |adolescent idiopathic scoliosis | ||
+ | |Musculoskeletal Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] |
− | |[[ | + | |[[SEC24B-AS1]] |
− | | | + | |1/2-SBSRNA4 |
− | | | + | |siRNA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137] |
− | |[[ | + | |[[PDZRN3-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |type 2 diabetes | ||
+ | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237] |
− | |[[ | + | |[[SCAANT1]] |
− | | | + | |ATXN7-AS1 |
− | | | + | |transcriptional regulation |
− | | | + | |pathogenic process |
+ | |spinocerebellar ataxia | ||
+ | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] |
− | |[[ | + | |[[AK123790]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] |
− | |[[ | + | |[[LINC01451]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] |
− | |[[ | + | |[[ZNF350-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |hepatocelluar cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845] |
− | |[[ | + | |[[GADD45G]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |pituitary adenoma | ||
+ | |Endocrine System Diseases;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410] |
− | |[[ | + | |[[Lnc-RASA1-3:23]] |
− | | | + | |AK082072,linc-POLR3G-8,ENSG00000247828 |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736] |
− | |[[ | + | |[[DAPK1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048] |
− | |[[ | + | |[[MAP3K14]] |
− | | | + | |MAP3K14 |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] |
− | |[[ | + | |[[PPP3CB]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |Pancreatic ductal adenocarcinoma | ||
+ | |Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] |
− | |[[ | + | |[[DAPK1-IT1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] |
− | |[[ | + | |[[GDNF-AS1]] |
− | | | + | |GDNFOS |
− | | | + | |transcriptional regulation |
− | | | + | |pathogenic process |
+ | |Alzheimer's disease | ||
+ | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] |
− | |[[ | + | |[[BIRC6-AS2]] |
− | | | + | |megamind |
− | | | + | |NA |
− | | | + | |developmental process |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] |
− | |[[ | + | |[[BIRC6-AS1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] |
− | |[[ | + | |[[LINC00854]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |NA |
+ | |NA | ||
+ | |NA | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] |
− | |[[ | + | |[[Uc.73]] |
− | | | + | |NA |
− | | | + | |NA |
− | |cancer | + | |pathogenic process |
+ | |colorectal cancer | ||
+ | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841] |
− | |[[ | + | |[[FR0257520]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |prostate cancer | ||
+ | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104] |
− | |[[ | + | |[[NRG1]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |lung cancer | ||
+ | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689] |
− | |[[ | + | |[[CDKN2B-AS11]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process;developmental process |
+ | |stroke | ||
+ | |Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690] |
− | |[[ | + | |[[CDKN2B-AS12]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |glioma | ||
+ | |Neoplasms | ||
+ | |- | ||
+ | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691] | ||
+ | |[[CDKN2B-AS13]] | ||
+ | |NA | ||
+ | |NA | ||
+ | |pathogenic process | ||
+ | |plexiform neurofibroma | ||
+ | |Neoplasms;Nervous System Diseases | ||
|- | |- | ||
− | | | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697] |
− | |[[ | + | |[[CDKN2B-AS7]] |
− | | | + | |NA |
− | | | + | |NA |
− | | | + | |pathogenic process |
+ | |acute lymphoblastic leukemia | ||
+ | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||